-
An Isogenic Cell Line Panel for Sequence-based Screening of Targeted Anti-cancer Drugs
Study
EGAS00001005974
-
Single cell genomic variation induced by mutational processes in cancer
Study
EGAS00001006343
-
Comprehensive epigenomic profiling reveals the extent of disease-specific chromatin states and informs drug target discovery in ankylosing spondylitis
Study
EGAS00001006233
-
Human genome-wide variations in the Massim region
Study
EGAS00001006010
-
Drug-induced epigenomic plasticity reprograms circadian rhythm regulation to drive prostate cancer towards androgen-independence (ChIP-seq)
Study
EGAS00001006017
-
EXCEED Study
Study
EGAS00001003499
-
Capture-based NGS
Dataset
EGAD00001011151
-
Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets
Study
EGAS00001006059
-
Conserved features of TERT promoter duplications reveal an activation mechanism that mimics hotspot mutations in cancer
Study
EGAS00001006118
-
Genetic immune escape landscape in primary and metastatic cancer
Study
EGAS00001006123